Last reviewed · How we verify
NCT04983927
Evaluation of Clinical Decision Support System for Scoring of ASPECT Score Using Brain CT Images
trial testing cASPECTS in Ischemic Stroke in 326 participants. Completed in 6 December 2021.
6 December 2021
Quick facts
| Lead sponsor | Heuron Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 326 |
| Start date | 11 August 2021 |
| Primary completion | 6 December 2021 |
| Estimated completion | 6 December 2021 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- cASPECTS
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
Sponsor
Heuron Inc.
Who can join
19 and older, any sex, with Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
cASPECTS is a software that has been pre-learned based on ASPECTS Score of ischemic stroke patients using brain CT images, and clinical decision support system for scoring ASPECTS score by automatically analyzing brain CT images by assisting the medical team. The specific aims of this study are to evaluate efficacy of cASPECTS for scoring ASPECTS Score compared to the sensitivity and specificity levels of human expert.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04983927
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Other Heuron Inc. trials
Trials by the same sponsor.
- NCT05513794 — Prospective Study for Neuromelanin Image Analysis · NA · completed
- NCT05573815 — Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images · NA · unknown
- NCT05572619 — Evaluation of Clinical Decision Support System for Large Vessel Occlusion Using Brain CT Images · completed
- NCT04983953 — Evaluation of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images · completed
- NCT04334902 — Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04983927 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heuron Inc.
- Last refreshed: 14 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04983927.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing